OCON Therapeutics

📍 Modiin, Israel🗓 Founded 2020👥 38 employees💰 Last funded Feb 2022
Pharmaceutical Manufacturing🌐 oconmed.com
Website LinkedIn
OCON Therapeutics develops innovative and safe intra-uterine medical solutions that are inspired by women’s bodies and anatomy, to better the lives of women everywhere. In the past decade we have developed the IUB™ platform, our proprietary intrauterine ball-shaped technology, utilising super-elastic alloy Nitinol to carry long lasting hormone-free contraception and other drugs. OCON’s first product, the IUB™ Ballerine®, is a CE approved copper-based hormone-free intrauterine contraceptive, effective for up to 5 years, and already in use by over 100,000 women in 24 countries, including EU member countries, South Africa and Israel. The Company is currently enlisting patients for its phase II clinical trials with the IUB™ SEAD, a disposable, point of care therapy for the treatment of abnormal uterine bleeding (AUB), affecting 25% of women in the reproductive age. The SEAD (Spherical Endometrial Ablation Device) is designed to be a pain-free, non-invasive and cost-effective alternative for aggressive, invasive, painful and costly ablation procedures hundreds of thousands of women currently endure. In addition, we are working on a strong pipeline of more IUB™ based drug products, using the frame for myomas and other uterine indications. OCON’s technology platform and products are protected by a broad portfolio of patents and trademarks.
5
Total investors
4
Early stage
0
Mid stage
1
Late stage
2020
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Sweden
1
Investor activity2018–2022 · investors recorded per year
20181202012021220221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in OCON Therapeutics?
OCON Therapeutics has 5 investors on record on gritt.io, including 4 early-stage backers and 1 late-stage investors.
When did OCON Therapeutics last raise funding?
The most recent investment in OCON Therapeutics recorded on gritt.io was in February 2022.
When was OCON Therapeutics founded?
OCON Therapeutics was founded in 2020.
What industry is OCON Therapeutics in?
OCON Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is OCON Therapeutics based?
OCON Therapeutics is headquartered in Modiin, Israel.